The theme of this project is the evaluation of newly available compounds modulating brain monoamine systems as potential treatments for cocaine or methamphetamine dependence. The selected medications have not yet been evaluated in patients with stimulant dependence, so assessment of their effects in this population will provide critical new information for the addiction research field. The proposed medications for cocaine dependence are RTI-336 and JD-Tic. RTI-336 is a selective inhibitor of the dopamine transporter (DAT) that reduces cocaine self-administration by rats and monkeys. JD-Tic is a long-acting, orally active kappa opioid antagonist that blocks stress-induced reinstatement of cocaine-seeking behavior in rats. Kappa opioid receptors are up-regulated in cocaine users, indicating that kappa opioid systems may play an important role in cocaine relapse. The proposed medications for methamphetamine dependence are YPK10A and SYN-115. YPK10A, previously known as R228060, has negligible activity at monoamine transporters and receptors but has a stimulant-like behavioral profile, suggesting that it may have a novel mechanism of action. YPK10A reduces cocaine self-administration in rats, suggesting that it has potential efficacy for treating stimulant dependence. SYN-115 is a selective adenosine-2a (A2a) receptor antagonist that reduces the rewarding effects of cocaine in the rat conditioned place preference test, probably by enhancing dopaminergic neurotransmission. Consistent with this, an A2a antagonist is undergoing late phase clinical trials for the treatment of Parkinson's disease. Overall, the planned phase I studies in this project will provide critical information regarding the safety and potential efficacy of these compounds as treatments for cocaine or methamphetamine dependence. We will use this information to design outpatient trials to evaluate medications as treatments for cocaine or methamphetamine dependence. In addition, we will use the results from these trials to define the phenotypes and to develop endophenotypes that will be used in the pharmacogenetic core to identify genetic factors associated with these variables.
Early phase research studies are needed to determine the safety and potential efficacy of new treatments for stimulant dependence. We propose four studies assessing the effects of novel medications combined with either cocaine or methamphetamine. The results we obtain will guide subsequent research aimed at identifying effective treatments for cocaine and methamphetamine dependence.
|Wachman, Elisha M; Hayes, Marie J; Lester, Barry M et al. (2014) Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome. J Pediatr 165:472-8|
|Graham, David P; Nielsen, David A; Kosten, Thomas R et al. (2014) Examining the utility of using genotype and functional biology in a clinical pharmacology trial: pilot testing dopamine ?-hydroxylase, norepinephrine, and post-traumatic stress disorder. Psychiatr Genet 24:181-2|
|Spellicy, C J; Harding, M J; Hamon, S C et al. (2014) A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study. Genes Brain Behav 13:559-64|
|Mahoney 3rd, James J; De La Garza 2nd, Richard; Jackson, Brian J et al. (2014) The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders. Psychiatry Res 219:367-71|
|Liu, Shijing; Green, Charles E; Lane, Scott D et al. (2014) The influence of dopamine ?-hydroxylase gene polymorphism rs1611115 on levodopa/carbidopa treatment for cocaine dependence: a preliminary study. Pharmacogenet Genomics 24:370-3|
|Mahoney 3rd, James J; Newton, Thomas F; Omar, Yasmine et al. (2013) The relationship between lifetime stress and addiction severity in cocaine-dependent participants. Eur Neuropsychopharmacol 23:351-7|
|Brewer 3rd, Alex J; Mahoney 3rd, James J; Nerumalla, Chandra S et al. (2013) The influence of smoking cigarettes on the high and desire for cocaine among active cocaine users. Pharmacol Biochem Behav 106:132-6|
|Kosten, Thomas R; Domingo, Coreen B; Hamon, Sara C et al. (2013) DBH gene as predictor of response in a cocaine vaccine clinical trial. Neurosci Lett 541:29-33|
|Haile, Colin N; Kosten, Thomas R (2013) Pharmacotherapy for stimulant-related disorders. Curr Psychiatry Rep 15:415|
|Ross, Elizabeth L; Yoon, Jin H; Mahoney 3rd, James J et al. (2013) The impact of self-reported life stress on current impulsivity in cocaine dependent adults. Prog Neuropsychopharmacol Biol Psychiatry 46:113-9|
Showing the most recent 10 out of 39 publications